Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V. F., . . . Rozencweig, M. (2014). Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol.
Chicago Style CitationBaselga, J., et al. "Phase III Trial of Nonpegylated Liposomal Doxorubicin in Combination With Trastuzumab and Paclitaxel in HER2-positive Metastatic Breast Cancer." Ann Oncol 2014.
Cita MLABaselga, J., et al. "Phase III Trial of Nonpegylated Liposomal Doxorubicin in Combination With Trastuzumab and Paclitaxel in HER2-positive Metastatic Breast Cancer." Ann Oncol 2014.
Atenció: Aquestes cites poden no estar 100% correctes.